These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 26654796)

  • 1. Role of the non-opioid dynorphin peptide des-Tyr-dynorphin (DYN-A(2-17)) in food intake and physical activity, and its interaction with orexin-A.
    Gac L; Butterick TA; Duffy CM; Teske JA; Perez-Leighton CE
    Peptides; 2016 Feb; 76():14-8. PubMed ID: 26654796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain site-specific regulation of hedonic intake by orexin and DYN peptides: role of the PVN and obesity.
    Mattar P; Uribe-Cerda S; Pezoa C; Guarnieri T; Kotz CM; Teske JA; Morselli E; Perez-Leighton C
    Nutr Neurosci; 2022 May; 25(5):1105-1114. PubMed ID: 33151127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects on Hedonic Feeding, Energy Expenditure and Balance of the Non-opioid Peptide DYN-A
    Alvarez B; Barrientos T; Gac L; Teske JA; Perez-Leighton CE
    Neuroscience; 2018 Feb; 371():337-345. PubMed ID: 29203229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Control of motivation for sucrose in the paraventricular hypothalamic nucleus by dynorphin peptides and the kappa opioid receptor.
    Sandoval-Caballero C; Jara J; Luarte L; Jiménez Y; Teske JA; Perez-Leighton C
    Appetite; 2024 Sep; 200():107504. PubMed ID: 38768926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Projection-Target-Defined Effects of Orexin and Dynorphin on VTA Dopamine Neurons.
    Baimel C; Lau BK; Qiao M; Borgland SL
    Cell Rep; 2017 Feb; 18(6):1346-1355. PubMed ID: 28178514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of ethanol on hypothalamic opioid peptides, enkephalin, and dynorphin: relationship with circulating triglycerides.
    Chang GQ; Karatayev O; Ahsan R; Avena NM; Lee C; Lewis MJ; Hoebel BG; Leibowitz SF
    Alcohol Clin Exp Res; 2007 Feb; 31(2):249-59. PubMed ID: 17250616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microinjection of dynorphin into the supraoptic and paraventricular nuclei produces antidiuretic effects through vasopressin release.
    Tsushima H; Mori M; Matsuda T
    Jpn J Pharmacol; 1993 Dec; 63(4):461-8. PubMed ID: 7907154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential target-dependent actions of coexpressed inhibitory dynorphin and excitatory hypocretin/orexin neuropeptides.
    Li Y; van den Pol AN
    J Neurosci; 2006 Dec; 26(50):13037-47. PubMed ID: 17167093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynorphin-related peptides cause motor dysfunction in the rat through a non-opiate action.
    Faden AI; Jacobs TP
    Br J Pharmacol; 1984 Feb; 81(2):271-6. PubMed ID: 6142741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Promotion of the Unfolding Protein Response in Orexin/Dynorphin Neurons in Sudden Infant Death Syndrome (SIDS): Elevated pPERK and ATF4 Expression.
    Hunt NJ; Waters KA; Machaalani R
    Mol Neurobiol; 2017 Nov; 54(9):7171-7185. PubMed ID: 27796753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Orexin (hypocretin)/dynorphin neurons control GABAergic inputs to tuberomammillary neurons.
    Eriksson KS; Sergeeva OA; Selbach O; Haas HL
    Eur J Neurosci; 2004 Mar; 19(5):1278-84. PubMed ID: 15016085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dietary fat stimulates endogenous enkephalin and dynorphin in the paraventricular nucleus: role of circulating triglycerides.
    Chang GQ; Karatayev O; Ahsan R; Gaysinskaya V; Marwil Z; Leibowitz SF
    Am J Physiol Endocrinol Metab; 2007 Feb; 292(2):E561-70. PubMed ID: 17283367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynorphin inhibits basal forebrain cholinergic neurons by pre- and postsynaptic mechanisms.
    Ferrari LL; Agostinelli LJ; Krashes MJ; Lowell BB; Scammell TE; Arrigoni E
    J Physiol; 2016 Feb; 594(4):1069-85. PubMed ID: 26613645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Orexin A (hypocretin 1) injected into hypothalamic paraventricular nucleus and spontaneous physical activity in rats.
    Kiwaki K; Kotz CM; Wang C; Lanningham-Foster L; Levine JA
    Am J Physiol Endocrinol Metab; 2004 Apr; 286(4):E551-9. PubMed ID: 14656716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypocretin (orexin) facilitates reward by attenuating the antireward effects of its cotransmitter dynorphin in ventral tegmental area.
    Muschamp JW; Hollander JA; Thompson JL; Voren G; Hassinger LC; Onvani S; Kamenecka TM; Borgland SL; Kenny PJ; Carlezon WA
    Proc Natl Acad Sci U S A; 2014 Apr; 111(16):E1648-55. PubMed ID: 24706819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Co-localization of hypocretin-1 and leucine-enkephalin in hypothalamic neurons projecting to the nucleus of the solitary tract and their effect on arterial pressure.
    Ciriello J; Caverson MM; McMurray JC; Bruckschwaiger EB
    Neuroscience; 2013 Oct; 250():599-613. PubMed ID: 23912034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Orexins/hypocretins modulate the activity of NPY-positive and -negative neurons in the rat intergeniculate leaflet via OX1 and OX2 receptors.
    Palus K; Chrobok L; Lewandowski MH
    Neuroscience; 2015 Aug; 300():370-80. PubMed ID: 26022361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Orexin activation counteracts decreases in nonexercise activity thermogenesis (NEAT) caused by high-fat diet.
    Bunney PE; Zink AN; Holm AA; Billington CJ; Kotz CM
    Physiol Behav; 2017 Jul; 176():139-148. PubMed ID: 28363838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Both dynorphin A(1-17) and [Des-Tyr1]dynorphin A(2-17) inhibit adenylyl cyclase activity in rat caudate putamen.
    Claye LH; Unterwald EM; Ho A; Kreek MJ
    J Pharmacol Exp Ther; 1996 Apr; 277(1):359-65. PubMed ID: 8613942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nociceptin/orphanin FQ peptide in hypothalamic neurones associated with the control of feeding behaviour.
    Maolood N; Meister B
    J Neuroendocrinol; 2010 Feb; 22(2):75-82. PubMed ID: 20025627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.